West Pharmaceutical Services, Inc.

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-07-12 pm EDT			5-day change	1st Jan Change
323 ^USD	-3.10%		+0.13%	-8.28%

Jul. 08	West Pharmaceutical Services Amends Credit Agreement to Establish $130 Million Incremental Term Loan	MT
Jul. 01	West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell Midcap Value Index	CI

West Pharmaceutical Services, Inc. authorizes a Buyback Plan.

December 09, 2019

The Board of Directors of West Pharmaceutical Services, Inc. has authorized a buyback plan on December 10, 2019.

Latest news about West Pharmaceutical Services, Inc.

West Pharmaceutical Services Amends Credit Agreement to Establish $130 Million Incremental Term Loan	Jul. 08	MT
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell Midcap Value Index	Jun. 30	CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 3000 Value Index	Jun. 30	CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 1000 Value-Defensive Index	Jun. 30	CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 1000 Value Index	Jun. 30	CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 3000E Value Index	Jun. 30	CI
West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing	Jun. 13	MT
Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM	Jun. 04
West Pharmaceutical Services, Inc. Introduces Daikyo Crystal Zenith® Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy	May. 29	CI
Transcript : West Pharmaceutical Services, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM	May. 14
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing	May. 09	MT
Declaration of Voting Results of the West Pharmaceutical Services Inc	Apr. 26	CI
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc	Apr. 26	CI
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating	Apr. 26	MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423	Apr. 26	MT
Health Care Drops Amid Mixed Earnings -- Health Care Roundup	Apr. 25	DJ
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.	Apr. 25	CI
West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised	Apr. 25	MT
Transcript : West Pharmaceutical Services, Inc., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400	Apr. 25	MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M	Apr. 25	MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29	Apr. 25	MT
West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
West Pharmaceutical Services, Inc. Reaffirms Earnings Guidance for the Full Year 2024	Apr. 25	CI
West Pharmaceutical Services, Inc. Announces Third Quarter 2024 Dividend, Payable on August 7, 2024	Apr. 25	CI

Chart West Pharmaceutical Services, Inc.

Duration

Period

Chart West Pharmaceutical Services, Inc.

More charts

West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-24 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for West Pharmaceutical Services, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

323 USD

Average target price

397.5 USD

Spread / Average Target

+23.08%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
WEST PHARMACEUTICAL SERVICES, INC.	-8.28%	23.53B
ABBOTT LABORATORIES	-5.31%	181B
MEDTRONIC PLC	-5.38%	99.95B
BECTON, DICKINSON AND COMPANY	-6.04%	66.21B
HOYA CORPORATION	+16.45%	45.4B
DEXCOM, INC.	-8.08%	45.36B
CENCORA, INC.	+8.38%	43.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.06%	29.03B
TERUMO CORPORATION	+17.98%	25.64B
ZIMMER BIOMET HOLDINGS, INC.	-10.69%	22.36B

Other Medical Equipment, Supplies & Distribution